• Je něco špatně v tomto záznamu ?

Hepatic arterial infusion of irinotecan, 5-Fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma

B. Melichar, Z. Voboril, A. Krajina, E. Malírová, P. Weiner, M. Nová, A. Ryska, J. Dvorák,

. 2012 ; 32 (12) : 5487-93.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024068

AIM: The aim of the present study was to evaluate single center experience with hepatic arterial infusion (HAI) of irinotecan, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma (CRC). PATIENTS AND METHODS: A retrospective analysis of 68 patients treated between 1998 and 2007 was performed. RESULTS: Among 60 patients who had no simultaneous liver-directed procedure (LDP), the best results obtained were complete response in two patients (3%), partial response in 18 patients (30%), and stable disease in 23 patients (38%), for an overall disease control rate of 72%. Median progression-free survival was 11 months, and median survival was 24 months. Overall survival was significantly better in patients with simultaneous LDP or secondary resection. Steatosis was present in all secondary resection specimens. CONCLUSION: Our data demonstrate the efficacy of HAI of irinotecan combined with 5-fluorouracil and leucovorin for liver metastases from CRC, specifically in patients also treated with LDP.

000      
00000naa a2200000 a 4500
001      
bmc13024068
003      
CZ-PrNML
005      
20130711100318.0
007      
ta
008      
130703s2012 gr f 000 0|eng||
009      
AR
035    __
$a (PubMed)23225456
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Melichar, Bohuslav $u Department of Oncology, Palacký University Medical School & Teaching Hospital, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
245    10
$a Hepatic arterial infusion of irinotecan, 5-Fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma / $c B. Melichar, Z. Voboril, A. Krajina, E. Malírová, P. Weiner, M. Nová, A. Ryska, J. Dvorák,
520    9_
$a AIM: The aim of the present study was to evaluate single center experience with hepatic arterial infusion (HAI) of irinotecan, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma (CRC). PATIENTS AND METHODS: A retrospective analysis of 68 patients treated between 1998 and 2007 was performed. RESULTS: Among 60 patients who had no simultaneous liver-directed procedure (LDP), the best results obtained were complete response in two patients (3%), partial response in 18 patients (30%), and stable disease in 23 patients (38%), for an overall disease control rate of 72%. Median progression-free survival was 11 months, and median survival was 24 months. Overall survival was significantly better in patients with simultaneous LDP or secondary resection. Steatosis was present in all secondary resection specimens. CONCLUSION: Our data demonstrate the efficacy of HAI of irinotecan combined with 5-fluorouracil and leucovorin for liver metastases from CRC, specifically in patients also treated with LDP.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a protokoly protinádorové kombinované chemoterapie $x aplikace a dávkování $7 D000971
650    _2
$a kamptothecin $x aplikace a dávkování $x analogy a deriváty $7 D002166
650    _2
$a kolorektální nádory $x farmakoterapie $x patologie $7 D015179
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluoruracil $x aplikace a dávkování $7 D005472
650    _2
$a arteria hepatica $7 D006499
650    _2
$a lidé $7 D006801
650    _2
$a intraarteriální infuze $7 D007261
650    _2
$a leukovorin $x aplikace a dávkování $7 D002955
650    _2
$a nádory jater $x farmakoterapie $x sekundární $7 D008113
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Voboril, Zbynek $u -
700    1_
$a Krajina, Antonín $u -
700    1_
$a Malírová, Eva $u -
700    1_
$a Weiner, Pavel $u -
700    1_
$a Nová, Markéta $u -
700    1_
$a Ryska, Ales $u -
700    1_
$a Dvorák, Josef $u -
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 32, č. 12 (2012), s. 5487-93
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23225456 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20130711100742 $b ABA008
999    __
$a ok $b bmc $g 987748 $s 822448
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 32 $c 12 $d 5487-93 $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Možnosti archivace